Tuesday, 02 January 2024 12:17 GMT

Middle East And North Africa (MENA) AI In Healthcare Market Forecast To 2035 43.0% CAGR Drives USD 15.0 Billion Opportunity In Smart Hospitals And Precision Medicine


Date:

(MENAFN- GlobeNewsWire - Nasdaq) Government AI initiatives, infrastructure investment, telehealth expansion and partnerships fuel adoption, with opportunities in provider tools and precision medicine.

Dublin, Oct. 22, 2026 (GLOBE NEWSWIRE) -- "Middle East and North Africa (MENA) AI in Healthcare Market: Distribution by Type of Platform, Type of Component, Type of Application, Type of Technology, End User and Leading Players: Industry Trends and Global Forecasts, Till 2035" has been added to ResearchAndMarkets.com's offering.

The Middle East and North Africa (MENA) AI in healthcare market is estimated at USD 0.6 billion in 2026 and is projected to reach USD 15.0 billion by 2035, expanding at a compound annual growth rate (CAGR) of 43.0% during the forecast period. Growth is being supported by government digital health programs, rising healthcare investment, expanding medical datasets, and demand for more precise diagnostics and personalized treatment.

Artificial intelligence is transforming disease detection, treatment planning, clinical decision-making, and patient monitoring across the MENA healthcare sector. AI technologies analyze medical images, laboratory results, electronic health records, and other clinical data to identify patterns associated with disease. Adoption is increasing in radiology, pathology, cardiology, oncology, precision medicine, clinical trials, and drug discovery.

Healthcare organizations are also implementing AI-powered clinical documentation, virtual assistants, administrative workflow tools, and decision-support platforms. These technologies can reduce administrative workloads, improve resource allocation, and allow healthcare professionals to focus on patient care. Connected medical devices and remote patient monitoring wearables further support continuous observation, earlier intervention, and preventive care.

Market Growth Drivers

The rising prevalence of diabetes, cardiovascular disease, and other non-communicable conditions is increasing demand for advanced diagnostic and disease management solutions. An aging population and growing pressure on healthcare infrastructure are also encouraging providers to adopt AI-enabled systems that improve efficiency and expand access to care.

Government initiatives are creating a strong foundation for market development. The UAE's National AI Strategy 2031 and Saudi Arabia's Vision 2030 prioritize investment in AI infrastructure, smart hospitals, digital health platforms, and data centers. These programs support real-time health information exchange, telehealth services, and more integrated care delivery.

Investment by global technology companies and regional funds is accelerating product development and commercialization. Platforms such as Seha Virtual Hospital and Aster DM's myAster app in Saudi Arabia demonstrate the growing role of virtual care in reaching underserved populations. Multi-omics technologies and expanding medical databases are also supporting personalized medicine based on genetic, clinical, and lifestyle information.

Challenges Affecting AI Adoption

Despite strong growth prospects, the MENA AI in healthcare market faces fragmented health records, inconsistent data quality, and limited interoperability. Incomplete datasets can reduce the accuracy and reliability of AI models, while outdated IT systems, weak internet connectivity, and insufficient computing resources can delay deployment, particularly in rural areas.

A shortage of healthcare professionals with AI expertise remains another important barrier. Limited digital skills, concerns about model interpretability, and resistance to workflow changes create a need for workforce training and structured implementation programs. Data privacy, cybersecurity, algorithmic bias, regulatory compliance, and equitable access also require coordinated action from governments, healthcare providers, technology developers, and investors.

Platform and End User Outlook

Based on platform type, the market is divided into solutions and services. Solutions currently account for the largest share and are expected to remain dominant as healthcare organizations deploy AI software for diagnostics, medical imaging, workflow management, and clinical decision-making. Product launches from companies such as Microsoft, including healthcare AI models in Azure AI Studio, Microsoft Fabric, and Copilot Studio, are broadening the availability of clinical and operational tools.

The services segment is expected to record faster long-term growth, supported by rising demand for telehealth, remote support, implementation services, and continuous patient monitoring.

Healthcare providers, including hospitals and outpatient facilities, currently represent the largest end user segment, accounting for approximately 45% of the market. Their leadership reflects increasing adoption of robot-assisted surgery, AI-driven remote patient monitoring, medical imaging tools, and machine learning applications. Healthcare companies are also expected to record substantial growth as pharmaceutical, biotechnology, and medical device organizations use AI for genome analysis, clinical trial optimization, predictive analytics, targeted therapy development, and drug discovery.

Market Segmentation

  • Platform: Solutions and services
  • Component: Hardware, software solution, services, and others
  • Application: Robot-assisted surgery, virtual assistants, administrative workflow assistants, connected medical devices, medical imaging & diagnostics, clinical trials, fraud detection, cybersecurity, dosage error reduction, precision medicine, drug discovery & development, lifestyle management & remote patient monitoring wearables, and other applications
  • Technology: Machine learning, natural language processing, context-aware computing, and computer vision
  • End User: Healthcare providers, healthcare payers, healthcare companies, patients, and other end users

Competitive Landscape

Companies examined in the report include GE Healthcare, Google, IBM, Intel Corporation, IQVIA, Medtronic, Microsoft, NVIDIA Corporation, Oracle, and Siemens Healthineers. Competition is expected to intensify as established technology companies, healthcare specialists, and regional innovators expand their AI capabilities through product development, investment, and strategic partnerships.

Report Scope and Business Value

The report evaluates market size, revenue forecasts, competitive positioning, growth drivers, adoption barriers, and opportunities across major market segments. It examines the number and profile of active providers, leading companies, country-level performance, emerging trends, market challenges, and the distribution of future opportunities by platform, component, application, technology, and end user.

The analysis supports established companies, investors, and new entrants seeking to assess customer demand, identify high-growth opportunities, develop market entry strategies, and make data-driven investment decisions. Buyers also receive complimentary Excel data packs covering analytical modules, up to 15% complimentary content customization, an in-depth walkthrough with the research team, and a complimentary update when the report is more than six months old.

Key Topics Covered:
1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Introduction
2.4.2.2. Types
2.4.2.2.1. Qualitative
2.4.2.2.2. Quantitative
2.4.2.3. Advantages
2.4.2.4. Techniques
2.4.2.4.1. Interviews
2.4.2.4.2. Surveys
2.4.2.4.3. Focus Groups
2.4.2.4.4. Observational Research
2.4.2.4.5. Social Media Interactions
2.4.2.5. Stakeholders
2.4.2.5.1. Company Executives (CXOs)
2.4.2.5.2. Board of Directors
2.4.2.5.3. Company Presidents and Vice Presidents
2.4.2.5.4. Key Opinion Leaders
2.4.2.5.5. Research and Development Heads
2.4.2.5.6. Technical Experts
2.4.2.5.7. Subject Matter Experts
2.4.2.5.8. Scientists
2.4.2.5.9. Doctors and Other Healthcare Providers
2.4.2.6. Ethics and Integrity
2.4.2.6.1. Research Ethics
2.4.2.6.2. Data Integrity
2.4.3. Analytical Tools and Databases
3. MARKET DYNAMICS
3.1. Forecast Methodology
3.1.1. Top-Down Approach
3.1.2. Bottom-Up Approach
3.1.3. Hybrid Approach
3.2. Market Assessment Framework
3.2.1. Total Addressable Market (TAM)
3.2.2. Serviceable Addressable Market (SAM)
3.2.3. Serviceable Obtainable Market (SOM)
3.2.4. Currently Acquired Market (CAM)
3.3. Forecasting Tools and Techniques
3.3.1. Qualitative Forecasting
3.3.2. Correlation
3.3.3. Regression
3.3.4. Time Series Analysis
3.3.5. Extrapolation
3.3.6. Convergence
3.3.7. Forecast Error Analysis
3.3.8. Data Visualization
3.3.9. Scenario Planning
3.3.10. Sensitivity Analysis
3.4. Key Considerations
3.4.1. Demographics
3.4.2. Market Access
3.4.3. Reimbursement Scenarios
3.4.4. Industry Consolidation
3.5. Robust Quality Control
3.6. Key Market Segmentations
3.7. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Overview of Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product (GDP)
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. R&D Innovation
4.2.11.7. Stock Market Performance
4.2.11.8. Supply Chain
4.2.11.9. Cross-Border Dynamics
5. EXECUTIVE SUMMARY
6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of Middle East and Africa (MENA) AI in Healthcare Market
6.2.1. Historical Evolution
6.2.2. Key Applications
6.2.3. Impact on Healthcare
6.3. Future Perspective
7. REGULATORY SCENARIO
8. COMPREHENSIVE DATABASE OF LEADING PLAYERS
9. COMPETITIVE LANDSCAPE
9.1. Chapter Overview
9.2. AI in Healthcare Market: Overall Market Landscape
9.2.1. Analysis by Year of Establishment
9.2.2. Analysis by Company Size
9.2.3. Analysis by Location of Headquarters
9.2.4. Analysis by Ownership Structure
10. WHITE SPACE ANALYSIS
11. COMPANY COMPETITIVENESS ANALYSIS
12. STARTUP ECOSYSTEM IN THE AI IN HEALTHCARE MARKET
12.1. AI in Healthcare Market: Market Landscape of Startups
12.1.1. Analysis by Year of Establishment
12.1.2. Analysis by Company Size
12.1.3. Analysis by Company Size and Year of Establishment
12.1.4. Analysis by Location of Headquarters
12.1.5. Analysis by Company Size and Location of Headquarters
12.1.6. Analysis by Ownership Structure
12.2. Key Findings
13. COMPANY PROFILES
13.1. Chapter Overview
13.2. Microsoft
13.2.1. Company Overview
13.2.2. Company Mission
13.2.3. Company Footprint
13.2.4. Management Team
13.2.5. Contact Details
13.2.6. Financial Performance
13.2.7. Operating Business Segments
13.2.8. Technology / Platform Portfolio
13.2.9. MOAT Analysis
13.2.10. Recent Developments and Future Outlook
13.3. Google
13.4. NVIDIA Corporation
13.5. Intel
13.6. GE Healthcare
13.7. Medtronic
13.8. Oracle
13.9. IQVIA
13.10. Siemens Healthineers
14. MEGA TRENDS ANALYSIS
15. PATENT ANALYSIS
16. RECENT DEVELOPMENTS
16.1. Chapter Overview
16.2. Recent Funding
16.3. Recent Partnerships
16.4. Other Recent Initiatives
17. MIDDLE EAST AND NORTH AFRICA (MENA) AI IN HEALTHCARE MARKET
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Trends Disruption Impacting Market
17.4. Demand Side Trends
17.5. Supply Side Trends
17.6. Middle East and Africa (MENA) AI in Healthcare Market, Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
17.7. Multivariate Scenario Analysis
17.7.1. Conservative Scenario
17.7.2. Optimistic Scenario
17.8. Investment Feasibility Index
17.9. Key Market Segmentations
18. MARKET OPPORTUNITIES BASED ON TYPE OF PLATFORM
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Revenue Shift Analysis
18.4. Market Movement Analysis
18.5. Penetration-Growth (P-G) Matrix
18.6. Middle East and Africa (MENA) AI in Healthcare Market for Solutions: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
18.7. Middle East and Africa (MENA) AI in Healthcare Market for Services: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
18.8. Data Triangulation and Validation
18.8.1. Secondary Sources
18.8.2. Primary Sources
18.8.3. Statistical Modeling
19. MARKET OPPORTUNITIES BASED ON TYPE OF COMPONENT
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Revenue Shift Analysis
19.4. Market Movement Analysis
19.5. Penetration-Growth (P-G) Matrix
19.6. Middle East and Africa (MENA) AI in Healthcare Market for Hardware: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
19.7. Middle East and Africa (MENA) AI in Healthcare Market for Software Solutions: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
19.8. Middle East and Africa (MENA) AI in Healthcare Market for Services: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
19.9. Middle East and Africa (MENA) AI in Healthcare Market for Others: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
19.10. Data Triangulation and Validation
19.10.1. Secondary Sources
19.10.2. Primary Sources
19.10.3. Statistical Modeling
20. MARKET OPPORTUNITIES BASED ON TYPE OF APPLICATION
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Revenue Shift Analysis
20.4. Market Movement Analysis
20.5. Penetration-Growth (P-G) Matrix
20.6. Middle East and Africa (MENA) AI in Healthcare Market for Robot-Assisted Surgery: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.7. Middle East and Africa (MENA) AI in Healthcare Market for Virtual Assistants: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.8. Middle East and Africa (MENA) AI in Healthcare Market for Administrative Workflow Assistants: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.9. Middle East and Africa (MENA) AI in Healthcare Market for Connected Medical Devices: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.10. Middle East and Africa (MENA) AI in Healthcare Market for Medical Imaging & Diagnostics: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.11. Middle East and Africa (MENA) AI in Healthcare Market for Clinical Trials: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.12. Middle East and Africa (MENA) AI in Healthcare Market for Fraud Detection: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.13. Middle East and Africa (MENA) AI in Healthcare Market for Cybersecurity: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.14. Middle East and Africa (MENA) AI in Healthcare Market for Dosage Error Reduction: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.15. Middle East and Africa (MENA) AI in Healthcare Market for Precision Medicine: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.16. Middle East and Africa (MENA) AI in Healthcare Market for Drug Discovery & Development: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.17. Middle East and Africa (MENA) AI in Healthcare Market for Lifestyle Management & Remote Patient Monitoring Wearables: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.18. Middle East and Africa (MENA) AI in Healthcare Market for Other Applications: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
20.19. Data Triangulation and Validation
20.19.1. Secondary Sources
20.19.2. Primary Sources
20.19.3. Statistical Modeling
21. MARKET OPPORTUNITIES BASED ON TYPE OF TECHNOLOGY
21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Revenue Shift Analysis
21.4. Market Movement Analysis
21.5. Penetration-Growth (P-G) Matrix
21.6. Middle East and Africa (MENA) AI in Healthcare Market for Machine Learning: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
21.7. Middle East and Africa (MENA) AI in Healthcare Market for Natural Language Processing: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
21.8. Middle East and Africa (MENA) AI in Healthcare Market for Context-aware Computing: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
21.9. Middle East and Africa (MENA) AI in Healthcare Market for Computer Vision: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
21.10. Data Triangulation and Validation
21.10.1. Secondary Sources
21.10.2. Primary Sources
21.10.3. Statistical Modeling
22. MARKET OPPORTUNITIES BASED ON END USER
22.1. Chapter Overview
22.2. Key Assumptions and Methodology
22.3. Revenue Shift Analysis
22.4. Market Movement Analysis
22.5. Penetration-Growth (P-G) Matrix
22.6. Middle East and Africa (MENA) AI in Healthcare Market for Healthcare Providers: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
22.7. Middle East and Africa (MENA) AI in Healthcare Market for Healthcare Payers: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
22.8. Middle East and Africa (MENA) AI in Healthcare Market for Healthcare Companies: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
22.9. Middle East and Africa (MENA) AI in Healthcare Market for Patients: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
22.10. Middle East and Africa (MENA) AI in Healthcare Market for Other End Users: Historical Trends (Since 2022) and Forecasted Estimates (Till 2035)
22.11. Data Triangulation and Validation
22.11.1. Secondary Sources
22.11.2. Primary Sources
22.11.3. Statistical Modeling
23. MARKET CONCENTRATION ANALYSIS: DISTRIBUTION BY LEADING PLAYERS
24. ADJACENT MARKET ANALYSIS
25. KEY WINNING STRATEGIES
26. PORTER'S FIVE FORCES ANALYSIS
27. SWOT ANALYSIS
28. ROOTS STRATEGIC RECOMMENDATIONS
28.1. Chapter Overview
28.2. Key Business-related Strategies
28.2.1. Research & Development
28.2.2. Product Manufacturing
28.2.3. Commercialization / Go-to-Market
28.2.4. Sales and Marketing
28.3. Key Operations-related Strategies
28.3.1. Risk Management
28.3.2. Workforce
28.3.3. Finance
28.3.4. Others
29. INSIGHTS FROM PRIMARY RESEARCH
30. REPORT CONCLUSION
31. TABULATED DATA
32. LIST OF COMPANIES AND ORGANIZATIONS
33. ROOTS SUBSCRIPTION SERVICES
34. AUTHOR DETAILS
A selection of companies mentioned in this report includes, but is not limited to:

  • GE Healthcare
  • Google
  • IBM
  • Intel Corporation
  • IQVIA
  • Medtronic
  • Microsoft
  • NVIDIA Corporation
  • Oracle
  • Siemens Healthineers

For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN22102026004107003653ID1111851096


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story

Search